Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

David Henry Mack net worth and biography

David Mack Biography and Net Worth

CEO of PMV Pharmaceuticals

Prior to co-founding PMV Pharma with biologists Arnold Levine and Thomas Shenk, Dr. Mack was a general partner at Alta Partners from 2002 to 2013. His first investment was Angiosyn (acquired by Pfizer in 2005) where he was a Director and CEO. Prior to Alta, Dr. Mack co-founded and served as Vice President of Genomics Research at Eos Biotechnology (acquired by Protein Design Labs in 2003).

From 1994 to 1997, he served at Affymetrix as Head of Cancer Biology where he oversaw the development and application of DNA array technology in the areas of oncology and inflammation. Dr. Mack was also a pivotal member of the Polymerase Chain Reaction (PCR) Invention Group at Cetus (now Novartis) in the mid 1980s. Dr. Mack has co-authored more than 30 scientific articles and reviews, including papers published in Cell, Science, and Nature, and is an inventor on 26 issued US patents. Dr. Mack was an American Cancer Society Postdoctoral Fellow in microbiology and immunology at Stanford University School of Medicine. He received his Ph.D. from the University of Chicago, where he was a Howard Hughes Fellow in Molecular Genetics and Cell Biology, and a B.A. in Molecular Biology from the University of California, Berkeley.

What is David Henry Mack's net worth?: The estimated net worth of David Henry Mack is at least $21,419.06 as of June 28th, 2021. Dr. Mack owns 12,674 shares of PMV Pharmaceuticals stock worth more than $21,419 as of April 25th. This net worth approximation does not reflect any other assets that Dr. Mack may own. Additionally, Dr. Mack receives an annual salary of $762,020.00 as CEO at PMV Pharmaceuticals. Learn More about David Henry Mack's net worth.
How old is David Henry Mack?: Dr. Mack is currently 62 years old. There are 3 older executives and no younger executives at PMV Pharmaceuticals. Learn More on David Henry Mack's age.
What is David Henry Mack's salary?: As the CEO of PMV Pharmaceuticals, Inc., Dr. Mack earns $762,020.00 per year. Learn More on David Henry Mack's salary.
How do I contact David Henry Mack?: The corporate mailing address for Dr. Mack and other PMV Pharmaceuticals executives is , , . PMV Pharmaceuticals can also be reached via phone at 609-642-6670 and via email at [email protected]. Learn More on David Henry Mack's contact information.
Has David Henry Mack been buying or selling shares of PMV Pharmaceuticals?: David Henry Mack has not been actively trading shares of PMV Pharmaceuticals within the last three months. Most recently, David Henry Mack sold 1,029 shares of the business's stock in a transaction on Tuesday, July 20th. The shares were sold at an average price of $35.53, for a transaction totalling $36,560.37. Learn More on David Henry Mack's trading history.
Who are PMV Pharmaceuticals' active insiders?: PMV Pharmaceuticals' insider roster includes Leila Alland (Insider), Richard Heyman (Director), Winston Kung (CFO), Arnold Levine (Director), David Mack (CEO), and Thilo Schroeder (Director). Learn More on PMV Pharmaceuticals' active insiders.
Are insiders buying or selling shares of PMV Pharmaceuticals?: During the last twelve months, insiders at the sold shares 2 times. They sold a total of 91,890 shares worth more than $222,931.26. The most recent insider tranaction occured on November, 22nd when Major Shareholder Orbimed Advisors Llc sold 87,786 shares worth more than $195,762.78. Insiders at PMV Pharmaceuticals own 7.6% of the company. Learn More about insider trades at PMV Pharmaceuticals.
Information on this page was last updated on 11/22/2023.

David Henry Mack Insider Trading History at PMV Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/20/2021	Sell	1,029	$35.53	$36,560.37
6/28/2021	Sell	204	$35.53	$7,248.12	12,674
5/21/2021	Sell	6,207	$35.71	$221,651.97	10,263

David Henry Mack Buying and Selling Activity at PMV Pharmaceuticals

PMV Pharmaceuticals Company Overview

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Today's Range

Now: $1.70

$1.66

$1.72

50 Day Range

MA: $1.69

$1.51

$1.93

2 Week Range

Now: $1.70

$1.18

$9.72

Volume

132,019 shs

Average Volume

535,169 shs

Market Capitalization

$87.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

See why the elites are pouring billions into gold.

David Mack Biography and Net Worth

What is David Henry Mack's net worth?

How old is David Henry Mack?

What is David Henry Mack's salary?

How do I contact David Henry Mack?

Has David Henry Mack been buying or selling shares of PMV Pharmaceuticals?

Who are PMV Pharmaceuticals' active insiders?

Are insiders buying or selling shares of PMV Pharmaceuticals?